-
1
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience
Published 2022-08-01“…Methods: We performed a retrospective review of 49 mRCC patients treated with ICI-based combination regimens in the standard of care setting at the Winship Cancer Institute of Emory University from 2015–2020. …”
Get full text
Article -
2
Venetoclax ex vivo functional profiling predicts improved progression-free survival
Published 2022-08-01Get full text
Article -
3
-
4
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience
Published 2023-02-01Get full text
Article -
5
ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah’s Witness congregation
Published 2019-12-01Get full text
Article -
6
-
7
Managing acute promyelocytic leukemia in patients belonging to the Jehovah’s Witness congregation
Published 2017-09-01Get full text
Article -
8
Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors
Published 2020-05-01Get full text
Article -
9
Learning-Based Stopping Power Mapping on Dual-Energy CT for Proton Radiation Therapy
Published 2021-02-01Get full text
Article -
10
Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era
Published 2023-01-01Get full text
Article -
11
-
12
-
13
-
14
-
15
Bisbiguanide analogs induce mitochondrial stress to inhibit lung cancer cell invasion
Published 2024-04-01Get full text
Article -
16
-
17
-
18
-
19
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
Published 2019-04-01Get full text
Article -
20
The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances
Published 2021-10-01Get full text
Article